找到约 59 条 “Gly6” 相关结果 (用时 0.113 秒)
目录号 | 产品名称 | 中文名称 | 靶点 |
---|---|---|---|
M12591 | ChemBridge-6146494 | ChemBridge化合物-6146494 | Screening Compounds and Building Blocks |
N-[3-(3-bromophenyl)-2-(2-furoylamino)acryloyl]glycine (6146494) | |||
ChemBridge特有类药化合物/先导化合物-6146494,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12625 | ChemBridge-6220207 | ChemBridge化合物-6220207 | Screening Compounds and Building Blocks |
N~1~-(2-bromophenyl)-N~2~-(4-ethoxyphenyl)-N~2~-(methylsulfonyl)glycinamide (6220207) | |||
ChemBridge特有类药化合物/先导化合物-6220207,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12671 | ChemBridge-6402712 | ChemBridge化合物-6402712 | Screening Compounds and Building Blocks |
N~1~-cyclopropyl-N~2~-(4-ethoxyphenyl)-N~2~-[(4-methylphenyl)sulfonyl]glycinamide (6402712) | |||
ChemBridge特有类药化合物/先导化合物-6402712,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12674 | ChemBridge-6432139 | ChemBridge化合物-6432139 | Screening Compounds and Building Blocks |
N-methyl-N-(6-nitro-1,3-benzothiazol-2-yl)glycine (6432139) | |||
ChemBridge特有类药化合物/先导化合物-6432139,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12768 | ChemBridge-6723028 | ChemBridge化合物-6723028 | Screening Compounds and Building Blocks |
ethyl 2-{[N-(2,3-dimethylphenyl)-N-(phenylsulfonyl)glycyl]amino}benzoate (6723028) | |||
ChemBridge特有类药化合物/先导化合物-6723028,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12771 | ChemBridge-6739985 | ChemBridge化合物-6739985 | Screening Compounds and Building Blocks |
methyl 2-({N-(2-methoxyphenyl)-N-[(4-methylphenyl)sulfonyl]glycyl}amino)benzoate (6739985) | |||
ChemBridge特有类药化合物/先导化合物-6739985,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12782 | ChemBridge-6809058 | ChemBridge化合物-6809058 | Screening Compounds and Building Blocks |
N-[4-(methylsulfonyl)-2-nitrophenyl]glycine (6809058) | |||
ChemBridge特有类药化合物/先导化合物-6809058,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12905 | ChemBridge-7361080 | ChemBridge化合物-7361080 | Screening Compounds and Building Blocks |
N-cyclohexyl-N-[(4-fluorophenyl)sulfonyl]glycine (7361080) | |||
ChemBridge特有类药化合物/先导化合物-7361080,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12909 | ChemBridge-7402683 | ChemBridge化合物-7402683 | Screening Compounds and Building Blocks |
methyl N-[4-(tert-butylamino)-6-(ethylamino)-1,3,5-triazin-2-yl]-N-cyanoglycinate (7402683) | |||
ChemBridge特有类药化合物/先导化合物-7402683,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M14813 | GPRP acetate | GPRP acetate | Peptides |
Gly-Pro-Arg-Pro acetate; Pefa 6003 acetate | |||
GPRP acetate (Gly-Pro-Arg-Pro acetate) 是一种纤维蛋白聚合抑制剂, 能够抑制纤维蛋白原与血小板膜糖蛋白 Ⅱb/IIIa 复合物(糖蛋白 IIb/IIIa 受体)之间的相互作用。 | |||
M24887 | Torapsel | Torapsel | Others |
42-89-glycoprotein; WAY164339; pMT21:PL85 | |||
Torapsel (42-89-glycoprotein; WAY164339) 是一种与免疫球蛋白融合的蛋白。Torapsel 可用于研究缺血再灌注损伤的预防。 | |||
M30472 | GPRP | GPRP | Integrin |
Gly-Pro-Arg-Pro; Pefa 6003 | |||
GPRP 是一种纤维蛋白聚合抑制剂,能够抑制纤维蛋白原与血小板膜糖蛋白 Ⅱb/IIIa 复合物(糖蛋白 IIb/IIIa 受体)之间的相互作用。 | |||
M45637 | ChemBridge-5634520 | ChemBridge化合物-5634520 | Screening Compounds and Building Blocks |
methyl N-(4-methylphenyl)-N-(methylsulfonyl)glycinate (5634520) | |||
ChemBridge特有类药化合物/先导化合物-5634520,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45776 | ChemBridge-6012256 | ChemBridge化合物-6012256 | Screening Compounds and Building Blocks |
N~1~-cyclopentyl-N~2~-(3,4-dimethoxyphenyl)-N~2~-[(4-methylphenyl)sulfonyl]glycinamide (6012256) | |||
ChemBridge特有类药化合物/先导化合物-6012256,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45845 | ChemBridge-6187162 | ChemBridge化合物-6187162 | Screening Compounds and Building Blocks |
N~1~-cyclopentyl-N~2~-(3-methoxyphenyl)-N~2~-(phenylsulfonyl)glycinamide (6187162) | |||
ChemBridge特有类药化合物/先导化合物-6187162,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45859 | ChemBridge-6226431 | ChemBridge化合物-6226431 | Screening Compounds and Building Blocks |
methyl N-(2-ethylphenyl)-N-(methylsulfonyl)glycinate (6226431) | |||
ChemBridge特有类药化合物/先导化合物-6226431,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45896 | ChemBridge-6388833 | ChemBridge化合物-6388833 | Screening Compounds and Building Blocks |
N~1~-bicyclo[2.2.1]hept-2-yl-N~2~-(3-methoxyphenyl)-N~2~-[(4-methylphenyl)sulfonyl]glycinamide (6388833) | |||
ChemBridge特有类药化合物/先导化合物-6388833,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45898 | ChemBridge-6403648 | ChemBridge化合物-6403648 | Screening Compounds and Building Blocks |
N~1~-bicyclo[2.2.1]hept-2-yl-N~2~-(3-methoxyphenyl)-N~2~-(phenylsulfonyl)glycinamide (6403648) | |||
ChemBridge特有类药化合物/先导化合物-6403648,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45918 | ChemBridge-6460000 | ChemBridge化合物-6460000 | Screening Compounds and Building Blocks |
N~1~-bicyclo[2.2.1]hept-2-yl-N~2~-(3,4-dimethoxyphenyl)-N~2~-(phenylsulfonyl)glycinamide (6460000) | |||
ChemBridge特有类药化合物/先导化合物-6460000,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45967 | ChemBridge-6664973 | ChemBridge化合物-6664973 | Screening Compounds and Building Blocks |
N~2~-benzyl-N~2~-[(2,5-dichlorophenyl)sulfonyl]-N~1~-methylglycinamide (6664973) | |||
ChemBridge特有类药化合物/先导化合物-6664973,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45989 | ChemBridge-6792161 | ChemBridge化合物-6792161 | Screening Compounds and Building Blocks |
N~2~-benzyl-N~2~-[(2,5-dichlorophenyl)sulfonyl]glycinamide (6792161) | |||
ChemBridge特有类药化合物/先导化合物-6792161,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M45996 | ChemBridge-6817802 | ChemBridge化合物-6817802 | Screening Compounds and Building Blocks |
N~1~-[4-(anilinosulfonyl)phenyl]-N~2~-(4-methoxyphenyl)-N~2~-(methylsulfonyl)glycinamide (6817802) | |||
ChemBridge特有类药化合物/先导化合物-6817802,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46049 | ChemBridge-7016027 | ChemBridge化合物-7016027 | Screening Compounds and Building Blocks |
N-(4-bromophenyl)-2-{[N-(2-hydroxyethyl)glycyl]amino}-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide (7016027) | |||
ChemBridge特有类药化合物/先导化合物-7016027,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46128 | ChemBridge-7356480 | ChemBridge化合物-7356480 | Screening Compounds and Building Blocks |
N-benzyl-N-[(2,5-dichlorophenyl)sulfonyl]glycine (7356480) | |||
ChemBridge特有类药化合物/先导化合物-7356480,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46190 | ChemBridge-7636042 | ChemBridge化合物-7636042 | Screening Compounds and Building Blocks |
N~1~-2-biphenylyl-N~2~-(2,3-dihydro-1,4-benzodioxin-6-yl)-N~2~-(methylsulfonyl)glycinamide (7636042) | |||
ChemBridge特有类药化合物/先导化合物-7636042,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46246 | ChemBridge-7742661 | ChemBridge化合物-7742661 | Screening Compounds and Building Blocks |
N~1~-bicyclo[2.2.1]hept-2-yl-N~2~-(2,3-dihydro-1,4-benzodioxin-6-yl)-N~2~-(phenylsulfonyl)glycinamide (7742661) | |||
ChemBridge特有类药化合物/先导化合物-7742661,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48121 | ChemBridge-44647926 | ChemBridge化合物-44647926 | Screening Compounds and Building Blocks |
N~1~-{[2-(3,4-difluorophenoxy)pyridin-3-yl]methyl}-N~2~-methylglycinamide (44647926) | |||
ChemBridge特有类药化合物/先导化合物-44647926,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48681 | ChemBridge-67485854 | ChemBridge化合物-67485854 | Screening Compounds and Building Blocks |
7-(1,3-benzothiazol-2-yl)-4-glycyl-2,3,4,5-tetrahydro-1,4-benzoxazepin-9-ol hydrochloride (67485854) | |||
ChemBridge特有类药化合物/先导化合物-67485854,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48807 | ChemBridge-73521846 | ChemBridge化合物-73521846 | Screening Compounds and Building Blocks |
N~1~-(biphenyl-4-ylmethyl)-N~2~-methyl-N~2~-piperidin-4-ylglycinamide (73521846) | |||
ChemBridge特有类药化合物/先导化合物-73521846,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M49283 | ChemBridge-96305102 | ChemBridge化合物-96305102 | Screening Compounds and Building Blocks |
4-(N,N-dimethylglycyl)-7-(2-methylphenyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-9-ol (96305102) | |||
ChemBridge特有类药化合物/先导化合物-96305102,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M1845
![]() |
LY335979 trihydrochloride | 唑喹达三盐酸盐 | P-glycoprotein |
Zosuquidar trihydrochloride; RS 33295-198 trihydrochloride | |||
Zosuquidar (LY335979) 3HCl是一种有效的P-glycoprotein(P-糖蛋白)介导的多药耐抗性的调节剂,Ki为60 nM。 | |||
M3909
![]() |
Glycyrrhizic acid | 甘草酸;甘草甜素 | HMGB1 |
NSC 167409; Glycyrrhizin | |||
Glycyrrhizic acid (NSC 167409) 是一种直接的高迁移率族蛋白1(HMGB1)的抑制剂,抑制依赖于HMGB1的炎症分子表达和氧化应激反应。Glycyrrhizic acid的生物活性代谢物是甘草次酸,Glycyrrhizic acid是11-β-羟基类固醇脱氢酶有效抑制剂。 | |||
M5881
![]() |
Piperine | 胡椒碱 | P-glycoprotein |
Bioperine; 1-Piperoylpiperidine | |||
Piperine是从胡椒中分离的天然生物碱,可以抑制P-glycoprotein and CYP3A4的活性,在HeLa细胞中的IC50值为61.94±0.054 μg/mL。 | |||
M11233
![]() |
Recombinant Human KRAS(G12C, His, E.coli) | 重组人 KRAS 蛋白 G12C( His, E.coli) | Cytokines and Growth Factors |
Ki-Ras; c-K-ras; KRAS2 | |||
重组人 KRAS 蛋白 (G12C, His) 由大肠杆菌表达系统产生,编码 Thr2-Cys185(Gly12Cys) 的靶基因在 N 末端用 6His 标签表达。 | |||
M8662 | PDD00017273 | PDD00017273 | Others |
PDD-17273 | |||
PDD00017273 是一种有效的、选择性的聚(ADP-核糖)糖水解酶 poly (ADP ribose) glycohydrolase (PARG)抑制剂,IC50为26 nM。PDD00017273催化 ADP-核糖聚合物的 O-糖苷键的水解,逆转聚(ADP-核糖)聚合酶 (PARP) 的作用。 | |||
M11496
![]() |
FGF-basic, Rat (E. coli) | FGF-basic, Rat (E. coli) | Cytokines and Growth Factors |
Fibroblast Growth Factor-basic; FGF-2; BFGF; FGFB; HBGF-2; bFGF; Prostatropin | |||
FGF-basic, Rat(E. coli) 蛋白构造:Expressed with an N-terminal Gly.FGF-basic (Pro10-Ser154) Accession # P13109。 生物活性:ED50 < 0.25 ng/ml,采用3T3细胞增殖法测定,对应> 4.0 × 106单位/mg。 | |||
M13442
![]() |
Recombinant Mouse IL-36 gamma (E.coli) | 重组小鼠 IL-36 gamma蛋白(E.coli) | Cytokines and Growth Factors |
IL-36 gamma(E.coli) | |||
重组小鼠IL-36 γ由我们的大肠杆菌表达系统产生,并表达了编码Gly13-Ser164的目的基因。 | |||
M19968
![]() |
Glycol chitosan | 乙二醇壳聚糖;羟乙基脱乙酰壳多糖 | Anti-infection |
Glycol chitin; deacetylated | |||
Glycol chitosan 乙二醇壳聚糖是一种具有亲水性乙二醇分支的壳聚糖衍生物。乙二醇壳聚糖增强甘氨酸max Harosoy 63W细胞的膜渗透性和铅。 | |||
M15078
![]() |
Recombinant Mouse Noggin/NOG (HEK293,C-6His) | 重组小鼠Noggin/NOG蛋白 (HEK293,C-6His) | Cytokines and Growth Factors |
Noggin; Nog | |||
Noggin is a secreted homodimeric glycoprotein that is an antagonist of bone morphogenetic proteins (BMPs). Noggin binds some BMPs such as BMP4 with high affinity and others such as BMP7 with lower affinity. It antagonizes BMP bioactivities by blocking epitopes on BMPs that are needed for binding to both type I and type II receptors. Accession # : P97466. | |||
M15084
![]() |
Recombinant Mouse Sonic Hedgehog/Shh (E.coli) | 重组小鼠 Sonic Hedgehog/Shh 蛋白(E.coli) | Cytokines and Growth Factors |
Sonic Hedgehog Protein; SHH; HHG-1; SHH | |||
利用大肠杆菌表达系统制备了重组小鼠Sonic Hedgehog基因,并表达了编码Cys25-Gly198的目的基因。Accession #: Q62226。 | |||
M16107 | Glycozolinine | 3-甲基-6-羟基咔唑 | Alkaloids |
Glycozolinine 3-甲基-6-羟基咔唑 | |||
M18181 | 6,7,4'-Trihydroxyisoflavone | 6,7,4'-三羟基异黄酮 | CDK |
Desmethylglycitein (4',6,7-Trihydroxyisoflavone),大豆苷元的代谢产物,来源于大豆 Glycine max,具有抗氧化性和抗癌活性。 | |||
M20644 | TH34 | TH34 | HDAC |
TH34 is a HDAC inhibitor that shows pronounced selectivity for HDACs 6, 8 and 10 over HDACs 1, 2 and 3. In a NanoBRET assay, TH34 strongly binds HDAC6, 8 and 10 with low-micromolar IC50 concentrations (HDAC6: 4.6 µM, HDAC8: 1.9 µM, HDAC10: 7.7 µM). | |||
M21677
![]() |
Recombinant Human Follistatin 288 (HEK293, C-6His) | 重组人Follistatin 288 蛋白 (HEK293, C-6His) | Cytokines and Growth Factors |
FST; follistatin isoform FST317 | |||
Follistatin 288 是一种分泌型糖蛋白,为卵巢卵泡液中的促卵泡激素抑制物质。人卵泡抑素 288 cDNA 编码具有 29 个氨基酸信号序列和 288 个氨基酸成熟区的 317 个氨基酸 (aa) 蛋白。重组人卵泡抑素/FST 由哺乳动物表达系统产生,编码 Gly30-Asn317 的靶基因在 C 末端用 6His 标签表达。 | |||
M21202
![]() |
Recombinant Human Lipocalin-2/NGAL/LCN2 (E. coli, C-6His) | 重组人Lipocalin-2/NGAL/LCN2 蛋白 (E. coli, C-6His) | Cytokines and Growth Factors |
Neutrophil gelatinase-associated lipocalin; NGAL | |||
人中性粒细胞明胶酶相关脂质运载蛋白(Lipocalin-2/NGAL/LCN2)由大肠杆菌表达系统生产,编码Gln21-Gly198的目标基因在C端有一个6His标签。Protein number:P80188。 | |||
M21448
![]() |
Recombinant Mouse IL-15RA (HEK293, C-Fc) | 重组小鼠IL-15RA 蛋白 (HEK293, C-Fc) | Cytokines and Growth Factors |
Interleukin-15 receptor subunit alpha | |||
重组小鼠白细胞介素15受体亚基α由哺乳动物表达系统产生,编码Gly33-Lys205的目标基因在c端带有Fc标签表达。蛋白编号:Q60819。 | |||
M21664
![]() |
Recombinant Human F13A (HEK293, C-6His) | 重组人凝血因子 XIII A 链蛋白 (HEK293, C-6His) | Cytokines and Growth Factors |
Coagulation Factor XIII A Chain | |||
重组人凝血因子 XIII A 链 (F13A) 由哺乳动物表达系统产生,编码 Gly39-Met732 的靶基因在 C 端用 6His 标签表达。凝血因子 XIII 是凝血级联反应中最后激活的酶原。血浆因子 XIII 是由 2 个 A 亚基和 2 个 B 亚基组成的异四聚体。A亚基具有催化功能,B亚基不具有酶活性。 | |||
M25536
![]() |
Recombinant Human CXCL13/BCA-1 (E. coli) | 重组人CXCL13/BCA-1蛋白 (E. coli) | Cytokines and Growth Factors |
CXC chemokine BLC; Small-inducible cytokine B13 | |||
CXCL13, also known as B-lymphocyte chemoattractant (BLC), is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Recombinant human CXCL13 is a single non-glycosylated polypeptide chain containing 87 amino acids and mature human BCA-1 shares 64 % amino acid sequence similarity with the murine protein and 23–34 % amino acid sequence identity with other known CXC chemokines. Determined by a chemotaxis bioassay using human B cells, the biological activity is in a concentration range of 1.0-10 ng/ml. | |||
M28216 | 6''-O-Acetylglycitin | 6''-O-Acetylglycitin | Others |
6''-O-Acetylglycitin 6''-O-乙酰黄豆黄苷是一种乙酰基葡萄糖苷,大豆异黄酮异构体之一,其含量根据储存温度,包装条件和异黄酮异构体种类不同会显示出不同程度的含量降低。 | |||
M31176
![]() |
Recombinant Human CD40L Protein (E. coli) | 重组人CD40L蛋白 (E. coli) | Cytokines and Growth Factors |
CD40 Ligand; CD154; TRAP | |||
CD40 Ligand (CD40L/CD154/TRAP) is a type II transmembrane glycoprotein that belongs to the TNF superfamily. The CD40 ligand stimulates B-cell proliferation and secretion of all immunoglobulin isotypes in the presence of cytokines. Recombinant Human CD40 Ligand is produced by E.coli expression system and the target gene encoding Met113-Leu261 is expressed. | |||
M38644 | Stearyl glycyrrhetinate | 硬脂醇甘草亭酸酯 | Antibiotic |
Stearyl glycyrrhetinate 是甘草提取物中的主要成分之一,对金黄色葡萄球菌菌株的 MIC 大于 256 mg/L。Stearyl glycyrrhetinate 具有抗菌 (antibacterial) 作用。 | |||
M38776 | 1-(26-Hydroxyhexacosanoyl)-glycerol | 1-(26-Hydroxyhexacosanoyl)-glycerol | Parasite |
1-(26-Hydroxyhexacosanoyl)-glycerol 是一种有效的抗疟剂。1-(26-Hydroxyhexacosanoyl)-glycerol 具有抗疟活性,对 Plasmodium falciparum 的 IC50 值为 9.48 µM。 | |||
M39028 | Picrotin | 苦亭 | GABA Receptor |
Picrotin 是一种活性化合物,也是 picrotoxin(GABAA 受体 (GABAARs) 和甘氨酸受体 (GlyRs) 的拮抗剂)的成分之一。Picrotin 对甘氨酸受体 (GlyRs) 具有敏感性,IC50 值范围为 5.2 μM 至 106 μM。 | |||
M39059 | Isoglycycoumarin | Isoglycycoumarin | Cytochrome P450 (e.g. CYP17) |
Isoglycycoumarin 是从Glycyrrhiza uralensis 根中提取的黄酮类化合物。Isoglycycoumarin 是一种高度选择性的人细胞色素 P450 2A6 (CYP2A6) 探针。 | |||
M39972 | Notoginsenoside T5 | Notoginsenoside T5 | Others |
Notoginsenoside T5 是一种 dammarane 61 glycoside. Notoginsenoside T5 是从 P. 62 notoginseng 的根皂苷酸性脱糖基中分离出来的。 | |||
M40606
![]() |
Recombinant Human C5a Protein (E.coli) | 重组人补体C5a (E.coli) | Cytokines and Growth Factors |
Complement C5; C5a anaphylatoxin | |||
Human Complement 5a (C5a) is an enzymatically generated glycoprotein that belongs to a family of structurally and functionally related proteins known as anaphylatoxins. Recombinant Human C5a expressed the target gene encoding Thr678-Arg751. | |||
M42282 | Dehydroglyasperin D | Dehydroglyasperin D | Aldose Reductase |
DeHydroglyasperin D 抑制大鼠和人醛糖还原酶 (Aldose Reductase (AR)) (IC50 分别为 62.4 μM 和 176.2μM)。 | |||
M45395
![]() |
1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | Others |
1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine是溴氰菊酯在体外被原核蛋白(CYP6A14和CYP6N6)复合物代谢的主要降解产物。 | |||
M50815 | Cbz-Glu-Gly-OH | Cbz-Glu-Gly-OH | Others |
Cbz-Glu-Gly-OH (NSC 186902) 是一种多肽,能够由多肽筛选发现。 |